This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
This is a web analytics service.
Processing company
  • Google Ireland Limited
  • Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
  • Facebook Ireland Limited
  • 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
  • advertising
  • Marketing
  • Retargeting
  • Analyse
  • Tracking
Technologies Used
  • Cookies
Data Attributes
  • Pixel specific data
  • Http-Header
  • Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • Facebook user ID
  • Browser information
  • Usage data
  • Geräteinformationen
  • Non-sensitive custom data
  • Referrer URL
  • Pixel ID
  • Location information
  • Pixel specific data
  • User behaviour
  • Ads viewed
  • Interactions with advertisement, services, and products
  • Marketing information
  • Content viewed
  • IP address
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Facebook Inc.
This is a web analytics service.
Processing company
  • Zoom Analytics Ltd.
  • Petah Tikva, Israel
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
Keeping Trust Through Health Preservation
21. December 2020.
In the year marked by the coronavirus pandemic, Hemofarm managed in the ever more demanding environment to produce and deliver medicines on time, in the required quantity and in the expected quality to the markets of Serbia and around the world, which the company considers its greatest business success in recent months. Confirmation for Hemofarm's work also came from the parent company Stada, which awarded the Serbian company within the Group for the successful functioning of the supply chain in 2020.

‘Hemofarm has confirmed its leadership position in this jubilee year, when it celebrates its 60th birthday, but above all, it has shown in action what the fight for human health means. Even in times of the greatest crises, we are expected to work smoothly and ensure a regular supply of medicines to the market. That is why, throughout the year, our goal was to provide safe working conditions for employees and to produce enough medicines for everyone - both for our citizens in Serbia and for consumers in the European Union, Russia, etc. We worked hard and I sincerely believe that our employees, together with health workers and pharmacists, were on the first line of health defense. That is why I am very grateful to all the people in Hemofam, in the production sites, in the field, as well as those who showed from their homes what we can achieve together, ’said Hemofarm CEO Dr Ronald Seeliger.

Ronald Zeliger Hemofarm

If we compare the business results in this atypical year with those achieved in 2019, Hemofarm increased the volume of production with a maintained level of 280 million packages. Namely, the volume of produced units increased by six percent, so that 6.5 billion tablets and other forms were produced in Hemofarm's plants this year.

Despite the difficulties that Covid-19 brought to the business environment, Hemofarm also managed to place 17 new products on the market, such as a medicine for the treatment of moderate to severe acute and chronic pain in adults (tapentadol molecule), and a state-of-the-art medicine for osteoporosis patients, a biosimilar teriparatide. Midol Protect 75, Probiotic Daily, Magnetrans Duo are just some of the new products in the company's portfolio.

During the state of emergency, Hemofarm paid a 10 percent salary incentive to employees who worked at production sites on a daily basis, and given the consequences that the pandemic leaves not only on people's physical but also mental health, the company implemented a psychological support program for employees together with Hemofarm Foundation. This program included individual interviews with a psychologist, forums and workshops with psychologists, as well as numerous professional texts available on the internal portal.

It is known that Hemofarm regularly helps health and other institutions, and that was especially important during the current pandemic crisis. Stada and Hemofarm donated 150 medical monitors worth about EUR 400,000 to Serbia, Bosnia and Herzegovina and Montenegro, the countries where they have production facilities. At the same time, Hemofarm Foundation supported Šabac and Vršac, cities where the company has production in Serbia, with five million dinars in the fight against coronavirus. In addition, protective equipment worth EUR 20,000 was donated to health workers in 18 primary healthcare centers in B&H.